Galmed Pharmaceuticals Ltd.
Develops oral therapeutics for liver, metabolic, and inflammatory diseases like NASH.
GLMD | NDAQ
Overview
Corporate Details
- ISIN(s):
- IL0011313900
- LEI:
- Country:
- United States of America
- Address:
- C/O MEITAR LAW OFFICES, 5250608 RAMAT GAN
- Website:
- https://www.galmedpharma.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company that develops oral therapeutics for liver, metabolic, and inflammatory diseases. The company's lead drug candidate, Aramchol, is in late-stage clinical development for the treatment of liver conditions such as Non-alcoholic steatohepatitis (NASH). Galmed focuses on leveraging its understanding of drug research and breakthrough mechanisms of action to deliver effective and safe lifetime medicines. The company's pipeline is highlighted by its ARMOR Phase 3 study for Aramchol, supported by the identification of a proprietary biomarker signature to potentially expand its therapeutic applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Galmed Pharmaceuticals Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Galmed Pharmaceuticals Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Galmed Pharmaceuticals Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
